TherapeuticsMD Ownership | Who Owns TherapeuticsMD?

Overview Forecast RevenueFinancials Chart

TherapeuticsMD Ownership Summary

TherapeuticsMD is owned by 29.30% institutional investors, 1.71% insiders, and 68.99% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 10.34% of TXMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.16% of its assets in TherapeuticsMD shares.

TXMD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TherapeuticsMD	29.30%	1.71%	68.99%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Specialty & Generic Drug Manufacturers Stocks	34.90%	10.53%	54.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rubric capital management lp	1.19M	10.34%	$1.92M
Clearline capital lp	636.62K	5.52%	$1.02M
Tejara capital	401.94K	3.49%	$647.12K
Vanguard group	387.58K	3.36%	$624.01K
Adar1 capital management	270.16K	2.34%	$434.96K
Morgan stanley	131.60K	1.14%	$211.88K
Blackrock	125.15K	1.09%	$201.50K
Geode capital management	95.48K	0.83%	$153.76K
Bridgeway capital management	34.00K	0.29%	$54.74K
State street	30.10K	0.26%	$48.46K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tejara capital	401.94K	0.24%	$647.12K
Adar1 capital management	270.16K	0.08%	$434.96K
Rubric capital management lp	1.19M	0.05%	$1.92M
Clearline capital lp	636.62K	0.03%	$1.02M
Bridgeway capital management	34.00K	0.00%	$54.74K
J. goldman & co lp	13.56K	0.00%	$21.84K
Tower research capital llc (trc)	3.53K	0.00%	$5.69K
Guardian wealth management	2.00	-	$3.00
Blackrock	125.15K	-	$201.50K
Geode capital management	95.48K	-	$153.76K

Top Buyers

Holder	Shares	% Assets	Change
Clearline capital lp	636.62K	0.03%	101.28K
Geode capital management	95.48K	-	10.69K
Tower research capital llc (trc)	3.53K	0.00%	1.90K
Ubs group	9.12K	-	1.30K
Bank of america corp /de/	487.00	-	87.00

Top Sellers

Holder	Shares	% Assets	Change
Clear harbor asset management	-	-	-25.81K
Prosperity consulting group	-	-	-24.50K
Two sigma securities	-	-	-14.36K
Renaissance	-	-	-13.70K
Gabelli funds	-	-	-12.00K

New Positions

Holder	Shares	% Assets	Change	Value
Activest wealth management	40.00	-	40.00	$64.00

Sold Out

Holder	Change
Assetmark	-1.00
Qube research	-2.00
Old point trust & financial services n a	-50.00
Royal bank of canada	-517.00
Banque cantonale vaudoise	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	34	-8.11%	3,378,926	-0.87%	29	3.35%	8	-	4	-60.00%
Jun 30, 2024	37	-13.95%	3,408,550	0.93%	29	3.45%	8	-38.46%	10	11.11%
Mar 31, 2024	43	16.22%	3,377,177	3.85%	29	3.17%	13	85.71%	9	-30.77%
Dec 31, 2023	37	-	3,251,847	9.41%	30	3.59%	7	-36.36%	13	116.67%
Sep 30, 2023	37	-13.95%	2,972,070	-1.18%	29	3.06%	11	-8.33%	6	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	249.66K	2.16%	-
Vanguard Institutional Extnd Mkt Idx Tr	122.23K	1.06%	-
Fidelity Extended Market Index	66.07K	0.57%	8.63K
Bridgeway Ultra-Small Company Market	34.00K	0.29%	-
BlackRock Extended Equity Market K	16.29K	0.14%	-7.00
Fidelity Series Total Market Index	15.32K	0.13%	4.00K
Fidelity Total Market Index	14.84K	0.13%	-
NT Ext Equity Mkt Idx Fd - NL	8.76K	0.08%	-
Gabelli ABC AAA	8.00K	0.07%	-
Schwab Total Stock Market Index	7.06K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 22, 2024	Collins Cooper C.	-	Buy	$7.10K
Aug 21, 2024	Collins Cooper C.	-	Buy	$2.04K
Dec 06, 2023	Walker Marlan D	Chief Executive Officer	Sell	$33.50K
Dec 07, 2023	Walker Marlan D	Chief Executive Officer	Sell	$10.19K
Apr 26, 2023	Walker Marlan D	Chief Executive Officer	Sell	$2.52K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	1	-
2023 Q4	-	2
2023 Q3	-	-
2023 Q2	-	2
2023 Q1	-	4

TXMD Ownership FAQ

Who Owns TherapeuticsMD?

TherapeuticsMD shareholders are primarily institutional investors at 29.30%, followed by 1.71% insiders and 68.99% retail investors. The average institutional ownership in TherapeuticsMD's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which TherapeuticsMD falls below.

Who owns the most shares of TherapeuticsMD?

TherapeuticsMD’s largest shareholders are Rubric capital management lp (1.19M shares, 10.34%), Clearline capital lp (636.62K shares, 5.52%), and Tejara capital (401.94K shares, 3.49%). Together, they hold 19.34% of TherapeuticsMD’s total shares outstanding.

Does Blackrock own TherapeuticsMD?

Yes, BlackRock owns 1.09% of TherapeuticsMD, totaling 125.15K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 201.5K$. In the last quarter, BlackRock decreased its holdings by -10.627K shares, a -7.83% change.

Who is TherapeuticsMD’s biggest shareholder by percentage of total assets invested?

Tejara capital is TherapeuticsMD’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 401.94K TherapeuticsMD shares, valued at 647.12K$.

Who is the top mutual fund holder of TherapeuticsMD shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of TherapeuticsMD shares, with 2.16% of its total shares outstanding invested in 249.66K TherapeuticsMD shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools